278650 — HLB BioStep Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
KR₩330bn
Enterprise Value
KR₩322bn
Revenue
KR₩53bn

Annual balance sheet for HLB BioStep Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Interim Report	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16,202	14,910	10,393	97,045	70,358
Net Total Accounts Receivable
Net Total Receivables	6,946	8,829	10,153	10,148	6,629
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29,228	28,579	31,178	112,424	79,413
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23,146	26,226	39,867	39,626	40,678
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	61,531	74,215	94,626	172,187	171,714
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,090	15,379	16,582	12,775	64,682
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	19,667	20,572	30,038	101,909	70,124
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	41,864	53,643	64,587	70,278	101,590
Total Liabilities & Shareholders' Equity	61,531	74,215	94,626	172,187	171,714
Total Common Shares Outstanding
Total Preferred Shares Outstanding